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The electrospinning of a thermo-responsive
polymer with peptide conjugates for phenotype
support and extracellular matrix production of
therapeutically relevant mammalian cells†
F. A. A. Ruiter, ‡a L. E. Sidney, b K. L. Kiick,c J. I. Segal,d C. Alexander a and
F. R. A. J. Rose *a
Current cell expansion methods for tissue engineering and regenerative medicine applications rely on the
use of enzymatic digestion passaging and 2D platforms. However, this enzymatic treatment significantly
reduces cell quality, due to the destruction of important cell-surface proteins. In addition, culture in 2D
results in undesired de-differentiation of the cells caused by the lack of 3D similarity to the natural extra-
cellular matrix (ECM) environment. Research has led to the development of thermo-responsive surfaces
for the continuous culture of cells. These thermo-responsive materials properties can be used to passage
cells from the surface when the cell culture temperature is reduced. Here we report the development of a
PLA/thermo-responsive (PDEGMA) blend 3D electrospun fibre-based scaffold to create an enzymatic-
free 3D cell culture platform for the expansion of mammalian cells with the desired phenotype for clinical
use. Human corneal stromal cells (hCSCs) were used as an exemplar as they have been observed to de-
differentiate to an undesirable myo-fibroblastic phenotype when cultured by conventional 2D cell culture
methods. Scaffolds were functionalised with a cell adherence peptide sequence GGG-YIGSR by thiol–
ene chemistry to improve cell adherence and phenotype support. This was obtained by functionalising
the thermo-responsive polymer with a thiol (PDEGMA/PDEGSH) by co-polymerisation. These incorpor-
ated thiols react with the norbornene acid functionalised peptide (Nor-GGG-YIGSR) under UV exposure.
Presence of the thiol in the scaffold and subsequent peptide attachment on the scaffolds were confirmed
by fluorescence labelling, ToF-SIMS and XPS analysis. The biocompatibility of the peptide containing
scaffolds was assessed by the adhesion, proliferation and immuno-staining of hCSCs. Significant increase
in hCSC adherence and proliferation was observed on the peptide containing scaffolds. Immuno-staining
showed maintained expression of the desired phenotypic markers ALDH, CD34 and CD105, while
showing no or low expression of the undesired phenotype marker α-SMA. This desired expression was
observed to be maintained after thermo-responsive passaging and higher when cells were cultured on
PLA scaffolds with 10 wt% PDEGMA/4 mol% PDEGS-Nor-GGG-YIGSR. This paper describes the fabrica-
tion and application of a first generation, biocompatible peptide conjugated thermo-responsive fibrous
scaffold. The ease of fabrication, successful adherence and expansion of a therapeutically relevant cell
type makes these scaffolds a promising new class of materials for the application of cell culture expansion
platforms in the biomaterials and tissue engineering field.
Introduction
Current methods of adherent mammalian cell expansion for
tissue engineering and regenerative medicine applications rely
usually on the use of 2D culture platforms, foetal bovine
serum containing media, and enzymatic digestion for cell
recovery. However, 2D culture of primary cells can result in
undesired de-differentiation,1–3 due to the lack of similarities
to the natural extracellular matrix (ECM) environment, and
enzyme passaging can significantly reduce cell quality,4–6 as a
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result of the destruction of important cell-surface proteins. In
recent years, thermo-responsive surfaces7,8 have been used as
supports for mammalian cell culture, as their changes in
physicochemical properties at upper or lower critical solution
temperatures (UCST, LCST) can facilitate cell detachment
without the need for enzymatic passaging.9–13 PNIPAM is the
most commonly used thermo-responsive polymer, however,
the presence of strong hydrogen bond donors and hydrogen
acceptors in its structure can lead to inter- and intra-chain
association entanglement.14 By comparison, PEG-based poly-
mers have a reversible phase transition that occurs without
chain entanglement. These polymers are therefore widely used
in the drug delivery and biological fields.7,10,15–17 Although,
the polymer phase transitions result in measurable “hydro-
philic-to-hydrophobic” behaviour changes, these differences
are often only moderate in terms of their effects on cell
adhesion. Accordingly, there is a need to generate materials,
which provide selective functionality for specific cells to
attach, while retaining their ability to release cells via a mild
temperature change at the end of the cell culture and expan-
sion period. We therefore selected a PEG-based polymer that is
amenable to functionalisation without loss of the thermo-
responsive behaviour, an attribute that has widely been shown
in the literature.15,16,18–20
Here we report the development of a new cell adhesion
peptide (GGG-YIGSR) functionalised thermo-responsive fibre-
scaffold based on co-electrospun poly(DL-lactide) (PLA) and
poly(di(ethylene glycol) methyl ether methacrylate)-co-poly(di
(ethylene-glycol) carboxylate ester ethyl thiol) (PDEGMA/SH,
Fig. 1A) for enzyme-free 3D mammalian cell culture. We have
exemplified this concept via the growth and recovery of human
corneal stromal cells (hCSCs) in non-serum containing media.
These cells were chosen as hCSCs display a well characterised
phenotypic change during conventional in vitro culture from a
keratocyte phenotype (quiescent, CD34+, ALDH+) to a
mesenchymal stem cell/fibroblast/myofibroblast phenotype
(proliferative, CD105+, α-SMA+).21 The laminin sequence
YIGSR was selected for this study as previous literature has
shown that interaction with this peptide sequence supports
hCSCs attachment and the maintenance of a quiescent kerato-
cyte phenotype.22
Co-spinning PLA with thermo-responsive polymers of
PDEGMA and a side-chain thiol-functionalised PDEGSH gener-
ated fibrous scaffolds with ‘click’ handles for peptide coupling.
The subsequent conjugation chemistries were carried out by
reacting norbornene-fuctionalised peptides (Nor-GGG-YIGSR,
Fig. 1C) with the side-chain thiols via a UV-mediated thiol–ene
reaction (Fig. 1B). Attachment of the peptides on the scaffolds
was confirmed by fluorescence labelling, ToF-SIMS and XPS
analysis. The resulting bioconjugate scaffolds were assessed
for their ability to support hCSCs culture by cell adhesion, pro-
liferation and immunocytochemistry assays. The phenotypic
profiling of hCSCs after thermo-responsive passaging was eval-
uated by flow cytometry analysis of key cell surface markers.
The combined assay data indicated that the expansion of
hCSCs could be conducted with high yield and retention of a
therapeutically desirable phenotype without using expensive
and potentially cell-damaging enzymatic methods. The ability
to culture, expand and recover therapeutically relevant cell
types makes these scaffolds a promising new class of materials
for application in many areas of regenerative medicine, where
cells are destined for the clinic.
Experimental
Polymer and peptide synthesis
Materials. Hexane, DMF, Fmoc deprotection agent pipera-
zine, activator N,N′-diisopropylcarbodiimide (DIC), and activa-
tor base Oxyma were purchased from Fisher Scientific
(Pittsburgh, PA, USA). Fmoc-alanine, Fmoc-glysine,
Fmocisoleucine, Fmoc-valine, Fmoc-tyrosin(t-butyl), Fmoc-
arginine(Boc), Fmoc-lysine(Boc), and Fmoc-serine(t-butyl) were
purchased from ChemPep, USA. All other materials were pur-
chased from Sigma-Aldrich, Switzerland.
General process of synthesis of poly(di(ethylene glycol)
methyl ether methacrylate-co-poly(di(ethylene-glycol) vinyl
ether (PDEGMA/OH). Di(ethylene glycol) methyl ether meth-
acrylate and di(ethylene glycol) vinyl ether in different ratios,
2-butanone, 1-dodecanethiol and recrystallised AIBN were
added in a dry 50 ml round bottom flask, degassed for 25 min
with N2, closed and heated to 60 °C for 1 h. The mixture was
cooled to room temperature (rt) and precipitated in hexane
(500 mL), resuspended in 2-butanone and precipitated in
hexane for an additional three times. The resultant polymer
was dried overnight and identified by 1D, 2D 1H-NMR, C13-
NMR and FT-IR (see ESI†).
General process of synthesis of poly(di(ethylene-glycol)
methyl ether methacrylate-co-poly(di(ethylene-glycol) thiol
(PDEGMA/SH). PDEGMA/OH (4.4 mmol), 200 ml toluene,
3-mercaptopropanoic acid (2.2 mmol), p-TSA (1.76 mmol) and
DTT (2.2 mmol) were added in a dry round bottom flask and
refluxed for 48 hours at 135 °C with a Dean stark trap. Toluene
was removed by rotary evaporation and the product was preci-
pitated in cold ether for three times. The resultant polymer
was dried under vacuum and identified by 1D, 2D 1H-NMR,
C13-NMR and FT-IR (see ESI†).
General process of synthesis of norbornene functionalised
peptides
Norbornene acid (Nor) functionalised peptide Nor-GGG-YIGSR
was synthesised on a Rink Amide Resin (ChemPep,
Wellington, FL) with a Liberty Blue™ peptide synthesizer
(CEM Corporation, United Kingdom). Amino coupling cycles
were as followed: Fmoc deprotection, 4× washing, coupling,
coupling, 2× washing. The N-terminus of each peptide was
functionalised by a norbornene acid end group using the same
coupling cycle. These norbornene functionalised peptide were
cleaved off the resin in a strong acid 95% trifluoracetic acid
(TFA), 2.5% deionised H2O, and 2.5% triisopropylsilane under
shaking for 4 h. Cleaved resin was filtered off, TFA was evapor-
ated until 20% of the volume was left, and peptide were preci-
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pitated three times in cold ethyl. Sample was re-suspended in
80% water and 20% acetonitrile (ACN), frozen in liquid nitro-
gen, and lyophilised. Dried peptide was then reconstituted in
the same water ACN acetic acid ratio and purified by prepara-
tive-scale reverse-phase high performance liquid chromato-
graphy (RP-HPLC) using a Waters Xbridge BEH130 Prep C-18
column. The mobile phase comprised gradients of degassed,
deionised water with 0.1% TFA and ACN with 0.1% TFA, at a
Fig. 1 Schematics of (A) the PDEGMA/PDEGSH (PDEGMA/SH) synthesis, (B) the formation of polymer–peptide derivative electrospun scaffolds, (C)
the chemical structure of the synthesised Nor-GGG-YIGSR peptide sequence. Nor (blue block) is the norbornene acid photo-reactive group, GGG
(green block) is used as a spacer and YIGSR (purple block) sequence previously identified to promote hCSCs proliferation. (D) FT-IR spectra from
pure Nor-GGG-YIGSR (red), PDEGMA/SH (green) and peptide functionalised PDEGMA/PDEGS-Pep by photo-initiated thiol–ene chemistry (purple).
The double bond from the norbornene acid disappeared and the amino groups of the peptide appeared on the FT-IR of the functionalised polymer–
peptide. (E) Cloud point hysteresis of PDEGMA, PDEGMA/PDEGOH (PDEGMA/OH), PDEGMA/PDEGSH (PDEGMA/SH) and PDEGMA/PDEGS-Nor-
GGG-YIGSR (PDEGMA/S-Pep) in water (2 mg ml−1). Arrows up are the heating spectra and arrows down are the cooling spectra. Transition tempera-
ture (Tt) shift down when polymer cools down. This is due to the aggregation of the polymer, which takes time to break up. PDEGMA/OH Tt is
slightly higher in temperature due to the additional hydrophilic group OH. PDEGMA/SH polymer shows an earlier Tt change than the PDEGMA and
PDEGMA/OH polymers as well as a slow steady slope when cooled.
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flow rate of 21 ml min−1. The peptide was detected by UV
absorbance at 214 nm, fractions were collected and lyophi-
lised. Molecular weight of the purified peptide was verified by
electrospray ionization mass spectrometry (ESI-MS,
AutospecQ, VG Analytical, Manchester, UK).
Blend electrospun scaffold fabrication and polymer–peptide
conjugation
Production of blended PLA with PDEGMA/SH electrospun
scaffolds. Electrospun solutions were prepared in Ac : DMF
(1 : 1) with PLA (25% w/v) and PDEGMA/SH (10 wt%) at rt by
stirring. Obtained scaffolds were fabricated using a Climate
Control EC-CLI platform with rotating target collector EM RTC
electrospin unit (IME Technologies, the Netherlands, Geldrop)
with a 0.8 mm internal diameter (21 gauge) flat tip needle. The
conducting surface was reduced to a width of 5 cm (appr.
100 cm2 surface area) by covering either side of the rotating
mandrel (7.5 cm diameter) with parafilm. The climate control
system was started 30 min before the run to obtain constant
temperature and humidity of 20 °C and 44% respectively. A
total volume of 2 ml polymer solution per run was used for
each scaffold batch. Applied voltage, needle-to-collection
mandrel distance and flow rate were set to 19 kV, 17.5 cm and
0.5 ml h−1 respectively.
Thiol–ene conjugation of PDEGMA/S-Nor-GGG-YIGSR or
electrospun scaffolds PLA and PDEGMA/S-Nor-GGG-YIGSR
blend. PDEGMA/SH polymer (1 eq.) was dissolved in PBS to a
concentration of 1 mg mL−1, 10 eq. TCEP was added and left
on a shaker in a cold room (8 °C). Nor-GGG-YIGSR (1 eq.) was
dissolve in DMSO and added to the polymer TCEP solution.
55 μL LAP solution of 13.4 mg mL−1 in PBS was added and
sample was placed under a 365 nm mercury spot UV lamp
(Blak-Ray(r) B-100 AP high intensity UV lamp, uUVP) at a
strength of 6 mW cm−2 in an ice. Samples were UV exposed for
15 min and a small sample was taken every 5 min to observe
the reaction ratio of the thiol–ene click reaction. Resultant
product was precipitated by warming, resuspended in cold
water and precipitated for three times. Product was dried over-
night and characterised by the Ellman’s assay and IR measure-
ments. In case of the electrospun scaffolds, the scaffold was
submerged in 1 mL PBS (5 mM EDTA, 7.4 pH), 10 eq. TCEP
was added and shaken for 30 min in a cold room (8 °C). 10 eq.
Nor-GGG-YIGSR and 55 µL LAP solution was added. This was
exposed to 365 UV at a strength of 6 mW cm−2 for 90 seconds
over ice. Scaffolds were washed with PBS before cell seeding.
Electrospun scaffold characterisation
Scanning electron microscope (SEM). For each obtained
scaffold a 1 × 1 cm sample was cut out of the centre, mounted
on a pin stubs (12.5 mm) with carbon tabs (12 mm) and gold
sputter coated for 300 s at 25 mA (EM SCD005, Leica
Microsystems). All scaffolds were analysed by SEM
(JSM-6060LV, Jeol Ltd Japan) at ×1000, ×2000, and ×5000 mag-
nifications (mag.) with six different fields of view captured for
each scaffold.
Fibre diameters and standard deviation measurements.
Fibre diameter measurements were performed with ImageJ
1.48v software, six SEM images were taken at ×5000 mag. with
20 fibre measurements per image (120 in total). Beads were
included in the measurements and measured on the widest
point of the bead. Mean fibre diameter and standard deviation
of the measurements were calculated using GraphPad Prism
software 7.01 software.
Time-of-flight secondary ion mass spectrometry (ToF-SIMS).
Scaffolds were attached to a glass slide by double-sided tape,
put into the ToF-SIMS and set under vacuum the night before
measurement to obtain a stable vacuum. Negative and positive
spectra were collected using an ION TOF, ToF-SIMS IV instru-
ment (Münster, Germany) equipped, with a bismuth liquid
metal ion gun (LMIG). A voltage of 25 kV and Bi3+ primary ion
source were used. The beam was directed at a 45° angle to the
sample with a beam spot of 1–2 µm in the high current
bunched mode. Three different points of the scaffolds of inter-
est of a surface area of 500 by 500 µm were taken with 256 ×
256 pixels, 15 scans (1 shot per pixel). Spectra obtained were
analysed and relevant peaks identified by IONTOF GmbH
SurfaceLab 6 Software, Germany. Spectra were normalised to
total ion count and calibrated with m/z = 1 (H+), 15 (CH3
+), 31
(CH3O
+), 55 (C3H3O
+), 57 (C3H5O
+) and 99 (C5H7O2
+) for posi-
tive spectra and m/z = 1 (H−), 12 (C−), 13 (CH2
−), 14 (CH3
−) and
15 (CH4
−) for negative spectra.
X-Ray photoelectron spectrometry (XPS). Samples (0.5 ×
0.5 cm cuts) were mounted onto XPS sample stubs and pinned
with a copper bar. All XPS analysis were carried out using a
Kratos Axis Ultra spectrometer using a mono-chromated alu-
minium X-ray gun, with a charge-compensating electron flood.
Elemental quantification was achieved using CASA software. A
linear background was applied to the C 1s high resolution
peaks and synthetic Gaussian/Lorentzian peak shapes used to
fit the peak components.
Cell culture
Materials. DMEM, trypsin, PBS, 2% gelatin stock, antiboitic–
antimycotic (AB/AM) buffer were purchased from Sigma-
Aldrich Co Ltd, Switzerland. Trypan Blue Solution (0.4%) was
purchased from Thermo Fischer Scientific, UK. Foetal bovine
serum (FBS), alamarBlue, TrypLE dissociation reagent, DMEM/
F-12 + Glutamax, KnockOut serum replacement (KSR), FGF-
basic (bFGF), MEM non-essential amino acids (NEAA) were
purchased from Gibco Life Technologies, UK. Human leukae-
mia inhibitory factor (hLIF) was purchased from Cell
Signalling Technologies, the Netherlands.
0.1% (v/v) gelatin coating of 2D cell culture surfaces. T75
and 24 well plates were coated with 0.1% (v/v) gelatin in PBS to
improve cell attachment. 0.1% (v/v) gelatin in PBS was made
up form stock solution (1% (v/v) gelatin), sterilised through a
0.2 µm filter. 200 ml or 3 ml, 24 well or T75 flask respectively
was added, agitated and incubated for 2 h at 37 °C. Excess
gelatin solution was removed before cell seeding. Coated T75
flasks were kept in 3 mL PBS in the fridge at 4 °C for up to a
week.
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hCSCs isolation. Tissue from human donors was used in
accordance with the tenets of the declaration of Helsinki, fol-
lowing consent obtained from the donors and/or their rela-
tives. Corneoscleral rims were obtained under an MTA from
Nottingham University Hospitals Trust and all work was per-
formed in accordance with the Human Tissue Authority.
Corneoscleral rims arrived fully anonymised, thus age, gender
and health status are unknown. Excess sclera was removed,
and the corneal epithelium and endothelium were gently
detached by scraping, resulting in the remaining stromal
tissue. This was divided into small pieces and digested in
1 mg mL−1 collagenase Type IA (Sigma Aldrich) for 7 h under
agitation at 37 °C. The digest solution was filtered through a
40 µm cell strainer, centrifuged, resuspended in culture media
(see below), cultured and cryo-preserved at passage number
2.23,24
hCSCs cell culture and passaging. hCSCs were cultured stem
cell medium (SCM; DMEM/F11 + GlutaMAX with 20 w/v%
KSR, 0.04 w/v% bFGF, 0.01 w/v% hLIF, 0.2 w/v% AB/AM and 1
w/v% MEM non-essential amino acids) in T75 flasks at 40 000
cells per cm2 in SCM and incubated at 37 °C, 5% CO2. Media
was changed every 2–3 days. Passaging was performed at 80%
confluency (7–9 days culture) using TripLE. Cells were used
experimentally at passage 3.
Scaffold preparation and sterilisation. Electrospun scaffolds
were cut into 1.5 cm by 1.5 cm squares which were fixed in
CellCROWN™ inserts (no filter, non-sterile, Z742380-12EA),
resulting in a scaffold surface area of 0.79 cm2. The fixed
scaffold in the inserts were transferred to a non-tissue culture
plastic 24 well plate, sterilised for 10 min under UV light at
800 energy level, incubated for 2 h at 37 °C in 1 mL of DMEM
containing 10 w/v% AB/AM (100 units per mL penicillin,
100 µg mL−1 streptomycin) and washed with PBS (3 × 1 mL).
Cell seeding on electrospun scaffolds. Cells were seeded
onto the scaffolds (1 ml per well, 60 000 cells per mL) in SCM
and incubated at 37 °C, 2% CO2. Media was changed every 2 to
3 days culture.
Proliferation study using the cell viability assay, Alamar
blue. Scaffolds were rinsed with warm Hank’s balanced salt
solution (HBSS, 37 °C) for 3 times. Alamar blue working solu-
tion (500 µL; 10 w/v% Alamar blue in DMEM) was added to
the scaffolds. Cells adherent to tissue culture plastic (24 well,
triplicate) served as a positive control and unseeded scaffolds
for a negative control. The Alamar blue and scaffolds were
incubated for 90 min at 37 °C and fluorescence intensity of
100 µl aliquots were analysed using a plate reader (TECAN,
infinite R M200, Männedrof, Switzerland at excitation wave-
length and bandwidth of 560 nm; 9 nm, emission wavelength
and bandwidth of 590 nm; 20 nm, number of flashes 25, inte-
gration time 20 s and a gain of 87). Number of cells were calcu-
lated with the use of a calibration curve of known hCSC
number (see Fig. S11†) and divided by the surface area of the
scaffolds or of a single well in a 24 well plate in case of the
TCPS control to obtain the number of cells per cm2. Alamar
blue assays were performed at day 0, 2, 5, 7 and 9 of culture.
In case of day 0, the cells were allowed to attach after seeding
for 6 h. Samples were assayed in-triplicate to be statistically
reliable.
Cell immunocytochemistry
Materials. para-Formaldehyde (pFA), bovine serum albumin
(BSA), glycine, Triton X-100, Donkey serum were purchased
from Sigma-Aldrich Co Ltd, Switzerland. 4′,6-Diamidino-2-phe-
nylindole (DAPI) was purchased from Santa Cruz
Biotechnology. Alexa-Flour 488-conjugated phalloidin was pur-
chased from New England Biolabs. Antibodies details can be
found in Table S1.†
Fixing hCSCs for immuno-staining. Media was removed at
day 9 of cell culture, scaffolds was rinsed with PBS, 1 ml 2
w/v% pFA per scaffolds was added and incubated for 10 min at
rt. Subsequently, the scaffolds with fixed cells were washed
with PBS for 3 times.
Immunocytochemistry of fixed hCSCs on electrospun
scaffolds. To observe cell morphology, phenotype expression
and ECM expression of the hCSCs on the different electrospun
scaffolds four different immuno-staining combinations were
selected, see Table S2† (see Table S1† for primary and second-
ary antibodies used).
Scaffolds were moved from the Cell CROWN™ and placed
in a new non-treated 24 well plate, 200 µL permeabilisation
buffer (0.1% Triton-X100 in PBS) was added per scaffold for
immunostaining combinations B, C and D and incubated for
10 min at rt. Permeabilisation buffer was removed and
scaffolds were washed with PBS (3×). All washing steps lasting
5 min each. 200 µL of blocking buffer (3% Donkey serum in
wash buffer; 1% BSA, 0.3 M glycine in PBS) was added per
scaffold for all immuno-staining combinations and incubated
for 1 h at rt.
Subsequently, 200 µL of primary antibody solution was
added according to the immuno-staining combination per
scaffold at the required dilution factor prepared in wash buffer
(1% BSA, 0.3 M glycine in PBS; see Table S2†). Samples were
incubated at 4 °C for 16 h. Negative controls were incubated in
wash buffer only. The primary antibody solutions were
removed, scaffolds were rinsed with wash buffer (3×).
Secondary antibodies (200 µL) were added per scaffold, includ-
ing negative controls and incubated for 1 h at rt in the dark
(covered in foil). Subsequently, washed with PBS (3×). Scaffolds
of combination C were incubated for 20 min in the dark in
200 µL actin solution (see dilution, Table S2†) and washed
with PBS (3×).
All nuclei were stained with DAPI. DAPI (200 µL) was added
per scaffold and incubated for 10 min at rt in the dark, washed
with PBS (3×) and stored in PBS at 4 °C.
Confocal microscopy imaging. Scaffolds were removed from
the PBS and placed on a coverslip. Images were measured with
a 4× and 20× lens of the upright fluorescence microscope
(BX51, Olympus) with images captured with a black and white
camera (XM-10, Olympus) and Cell^F software (Olympus).
Wavelength of 405 nm, 488 nm and 566 nm for DAPI, CD34/
ALDH/actin/collagen I and CD105/α-SMA/Vimentin/Lumican,
respectively were used.
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hCSCs thermo-responsive detachment studies and phenotype
expression after detachment by flow cytometry
hCSCs thermo-responsive detachment studies. Scaffolds
were removed from the Cell CROWN™ and placed in a new
non-tissue culture treated 24 well plate and submerged in
1 mL SCM. This well plate was incubated for 30 min at 4 °C.
Scaffolds were vigorously agitated in the SCM media.
Subsequently, the SCM with detached cells were moved into a
new tissue-culture treated 24 well plate and incubated for 6 h
before performing the Alamar blue viability assay. The remain-
ing scaffolds were left in the well plate and new SCM 1 mL was
added and incubated for 6 h and subsequently the Alamar
blue viability assay was performed, to see if any cells were
remaining on the scaffold after detachment.
Percentage of cells detached was calculated by subtracting
the number of cells on the scaffold left after passaging with
the initial number of cells before passaging. This number was
then defined by initial number of cells and multiplied by 100.
Immunostaining of suspended cells for flow cytometry.
hCSCs were thermo-responsively detached from the scaffolds,
re-suspended in 2 w/v% pFA and fixed for 30 min, centrifuged
(5 min at 500g) and re-suspended in PBS. Samples were
stained in combinations A and B (see Table S2†), washed
between every step by centrifugation (3× for 5 min at 300g each
washing step). CD34, CD105, ALDH and α-SMA on their own
were used as positive control, while, the negative control was
incubation with the secondary antibody alone (without the
primary antibodies).
Flow cytometry. Flow cytometry was performed (MoFLo
Astrios™ Beckman Coulter, USA) to quantify cell populations
expressing certain markers of interest. Samples were agitated
before analysis to assure single cells were in suspension. Data
obtained were analysed by Kaluza Analysis software and
obtained X-means and Y-means were analysed with two-way
ANOVA using GraphPad Prism 7.01 software.
Characterisation techniques
1D 1-hydrogen and carbon-13 NMR analysis (1H-NMR and
C13-NMR). 1H-NMR and C13-NMR spectra were recorded on a
Bruker Avance III 400 spectrometer at 399.8 MHz (1H) and
100.5 MHz (C13) in deuterium chloroform (CDCl3).
MestReNova 11.0 software was used to analyse the obtained
spectra. All chemical shifts are reported in part per million
(ppm) relative to CDCl3 (7.24 ppm for
1H-NMR and 77.2 ppm
for C13-NMR) or tetramethylsolane (TMS).
2D-NMR heteronuclear single-quantum correlation spec-
troscopy analysis (HQSC). HSQC 2D-NMR spectra was recorded
on a Bruker Avance III 400 spectrometer at 399.8 MHz in
CDCl3. MestReNova 11.0 software was used to analyse the
obtained spectra. All chemical shifts are reported in part per
million (ppm) relative to CDCl3 (7.24 ppm for
1H-NMR and
77.2 ppm for C13-NMR).
Gel permeation chromatography (GPC) analysis. Molar
masses of the polymers were measured in tetrahydrofuran
(THF) eluent. THF samples were measured using a Waters
GPC (Milford, MA) with two Water Styragel (HR1 and HR4)
columns, a Waters 2695 auto-sample pump and a refractive
index (RI) detector (Waters 410). Samples were eluted at 40 °C
at a flow rate of 1.0 mL min−1. Calibration was performed
using linear poly(methyl methacrylate) (PMMA) standards
(Polymer Laboratories) in the molecular weight range
1–1200 kDa. Molecular weights and dispersity values were cal-
culated using Cirrus GPC 3.0. The samples were dissolved in
THF in a concentration of 10 mg mL−1 and filtered through
0.45 µm filters to remove any big particles and unwanted
impurities.
Fourier transform infra-red (FT-IR) analysis. Samples were
measured using an Agilent FT-IR spectrometer, Agilent
Technologies, UK. Solid samples were put on top of the
diamond, pressure was applied and spectra measured.
Measurement of polymer solution cloud points to estimate
lower critical solution temperature (LCST). Thermo-responsive
polymer solution (1 mL; 2 mg ml−1 in dH2O) was added into
an ultraviolet-visible (UV/VIS) cuvette and placed into the UV/
VIS equipment. The chamber was cooled to 5 °C before
measurement using a Quantum Northwest Peltier-Controlled
Cuvette Holder (Quantum Northwest Inc, WA, USA). UV-VIS
absorbance was measured by Agilent Technologies Cary 60 UV/
VIS (Santa Clara, CA, USA) at 550 nm wavelength while the
solution was heated at 60 °C at a rate of 1 °C min−1, incubated
at 60 °C for 5 min and cooled to 5 °C at 1 °C min−1. An
approximation of the LCST was determined at the solution
cloud point temperature when a non-linear increase of the
absorbance was observed.
Free thiol confirmation by the Ellman’s assay. Cysteine
hydrochloride monohydrate standard curve solutions of final
concentrations of 0, 0.25, 0.5 to 1.5 mM and Ellman’s reaction
solution (4 mg in 1 ml reaction buffer (0.1 M sodium phos-
phate and 1 mM EDTA, pH 8.4) were prepared. Cysteine stan-
dard curve solution (250 μL) was added to 2.5 mL reaction
buffer and 50 μL Ellman’s solution, mixed and incubated for
15 min at rt. UV absorbance was measured by Agilent
Technologies Cary 60 UV-Vis (Santa Clara, CA, USA) at 412 nm
wavelength. A standard curve was fitted (R2 = 0.99), with the
resulting equation Abs = 1.108 × number of free thiols was
used as reference for number of free thiols in the PDEGMA/SH
solution samples (see Fig. S8B†). PDEGMA/SH polymer
samples of 2 mg mL−1 were prepared. 250 μL polymer solution
was added to 2.5 mL reaction buffer and 50 µL Ellman’s
reagent solution, incubated for 15 min at rt, and absorbance
measured at 412 nm. Percentage free thiol were calculated by
the following equation. Percentage free thiols = (mmol
polymer per mmol free thiols) × 100.
Free thiol presents in polymers and blend electrospun
scaffolds confirmation by flouresceine-5-maleimide labelling.
One drop of 100 mL (4 mg ml−1, PDEGMA/SH polymer in
acetone) was dried on a glass slide. The dried polymers on the
glass slides or electrospun PLA + PDEGMA/SH blend scaffolds
were submerged in 3 mL PBS (5 mM EDTA). 30 µL TCEP solu-
tion (0.1 mg ml−1, 10 eq.) and incubated for 30 min at rt.
Flouresceine-5-maleimide solution (0.01 mg mL−1 in PBS) was
Paper Biomaterials Science
Biomater. Sci. This journal is © The Royal Society of Chemistry 2020
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
2 
A
pr
il 
20
20
. D
ow
nl
oa
de
d 
on
 4
/1
6/
20
20
 8
:2
8:
15
 A
M
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
added to the glass slide or scaffolds (1 : 1 ratio, SH : maleimide
group), incubated for 30 min at rt and washed with PBS (3×)
and imaged under confocal; images where enhanced to
observed lower signals on the fibres.
Peptide presence confirmation by ATTO-NHS-ester. Blend
electrospun scaffolds were submerged in 3 mL PBS (5 mM
EDTA). 30 µL TCEP (0.1 mg ml−1, 10 eq.) was added, incubated
for 30 min at rt. 10 eq. Nor-GGG-YIGSR and 55 µL LAP solution
was added, exposed to a 365 UV lamp at a strength of 6 mW
cm−2 for 90 seconds over ice. Scaffolds were washed with de-
ionised water; a stock solution of 0.01 mg mL−1 ATTO-NHS-
ester was then added to scaffolds (1 : 1 ratio, peptide : ATTO
group), incubated for 30 min at rt and washed with PBS (3×)
and imaged under confocal; images where enhanced to
observed lower signals on the fibres.
Results and discussion
Polymer synthesis
The co-polymers PDEGMA/SH in different ratios (100 : 0, 98 : 2,
97 : 3, 96 : 4, and 90 : 10, PDEGMA to PDEGSH respectively)
were synthesised by a two-step route (scheme. Fig. 1A).
PDEGMA/PDEGOH polymer was synthesised by free radical
synthesis with subsequent thiol functionalisation via a con-
densation reaction to form the PDEGMA/SH product.
Structures were confirmed by 2D-NMR analysis (Fig. S1–S18†)
with the disappearance of the CH̲2OH signal (H
1-NMR;
3.7–3.8 ppm, t, 2H and C13-NMR; 61 ppm) and the appearance
of the CH̲2SH peaks (H
1-NMR; 2.9 ppm, t, 2H and C13-NMR;
34 ppm) in the H1 and C13-NMR of the end product PDEGMA/
SH (Fig. S1–18 for NMR and Table S3† for GPC). Percentages
of free thiol in the co-polymers were confirmed by the
Ellman’s assay (Table 1). The phase transition temperatures
(Tt) of the polymers were estimated by cloud point measure-
ments (Fig. 1E, S19 and Table S4†). The norbornene functiona-
lised peptide Nor-GGG-YIGSR was synthesised on a rink amide
resin, purified by HPLC and its structure verified by electro-
spray ionisation mass spectrometry (ESI-MS, Fig. S20†). Upon
reaction of the peptide with the thiolated polymer, a decrease
in percentage of free thiols was observed at increasing UV
exposure times (0, 5, 10 and 15 min), with a conversion of 65%
after 15 min (Table 1). Fourier-transform infrared (FT-IR) ana-
lysis showed the disappearance of the norbornene double
bond (1530 cm−1) and the appearance of the amino-groups
(1655 cm−1) of the peptide in the case of the reacted peptide-
thiol polymer (Fig. 1D). Cloud point measurements of the
PDEGMA/S-Nor-GGG-YIGSR derivatised polymer showed tran-
sition temperatures (22 °C when heated and <18 °C when
cooled, Fig. 1E and Table S4†), as compared with the
PDEGMA/SH precursor, confirming retention of thermo-
responsive behaviour after peptide-functionalisation.
Electrospun scaffold fabrication and characterisation
The obtained PDEGMA/SH polymers were successfully blend
electrospun with PLA into uniform fibres (19 kV, 17.5 cm,
0.5 mL h−1 and 25 w/v% PLA and 10 wt% PDEGMA/SH
polymer in Ac/DMF) with an average fibre diameter range of
800–1200 nm (Fig. S22 and Table S5,† optimised via previous
DoE work25). XPS analysis and fluorescence labelling con-
firmed the presence of free thiols (S(2p) peak at 168.9 eV and
fluorescein-5-maleimide labelling respectively) and peptide
(N(1s) peak at 399.8 eV and ATTO NHS ester labelling respect-
ively) on the surface of the scaffolds (Fig. S22 and Table S6†).
The distributions of the free thiols and peptides on the
scaffolds surface were investigated further by ToF-SIMS ana-
lysis. Mass spectrometry peaks of the ion fragments were
identified and confirmed through literature (Table S7†).26–29
The ion fragment CH3O
− attributed to the underivatised
PDEGMA was present on the surface, and a decrease in peak
intensity of CH3O
− was observed for all the scaffolds contain-
ing PDEGMA/SH co-polymer (Fig. 2A). ToF-SIMS peak distri-
bution images indicated that SH groups were in regions corres-
Table 1 Percentage of detected free thiol groups in the synthesised PDEGMA/SH polymers after the condensation reaction. Detection and free
thiol group concentration estimation were carried out via an Ellman’s assay by detecting the absorbance of the Ellman’s assay reaction product. %
OH = percentage of OH on the starting polymer before thiol functionalisation. Cpolymer = concentration of polymer in PBS, Abs = absorbance at
412 nm, Cthiols = concentration of thiols calculated from standard curve, and conv. = conversion
Percentage of free thiols in co-polymers
% PDEGOH Cpolymer [mmol ml
−1] Abs Cthiols [mmol ml
−1] % PDEGSH
2 70 × 10−4 0.0877 1.2 × 10−4 1.7
3 70 × 10−4 0.1249 1.5 × 10−4 2.2
4 70 × 10−4 0.2483 2.6 × 10−4 3.7
10 70 × 10−4 0.7328 6.8 × 10−4 9.7
Percentage of free thiols after thiol–ene chemistry
UVtime [min] Cpolymer [mmol ml
−1] Abs Cthiols [mmol ml
−1] % PDEGSH % conv.
0 70 × 10−4 0.2483 2.6 × 10−4 3.7 0
5 19 × 10−4 0.0300 6.8 × 10−4 2.0 46
10 19 × 10−4 0.0295 6.8 × 10−4 2.0 46
15 70 × 10−4 0.0537 0.9 × 10−4 1.3 65
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ponding to the fibre positions on the substrate (Fig. 2C and
Fig. S22†). An even in S− and SH− absorptions were detected
for the free thiols on the fibrous surface, confirming an even
thiol–ene active distribution sides. A decrease in S− and SH−
absorptions were detected for the thiol–ene derivatised
scaffolds (Fig. 2A). The CNO− peak of the peptide amino-
groups were observed for all scaffolds incubated with peptide
(Fig. 2A). Significantly higher intensity was detected for the
Fig. 2 (A) Total intensity of the ToF-SIMS peaks CH3O
− (31 m/z), SH− (33 m/z) and S− (32 m/z) from the free thiol containing scaffolds. (B) Total
intensity of different sequences of the Nor-GGG-YIGSR peptide presences on the scaffold surfaces, (R(–NH2, 147 m/z), GSR(–COOOH, 326 m/z),
IGSR(–NH2, 425 m/z), GGGYIGS(–COOH, 605 m/z), GGGYIGSR(–COOH, 628 m/z) and GGGYIGSR(765 m/z) (n = 3 measurements areas on one
scaffold each, data normalised against total count, error bar = SD). (C) ToF-SIMS signal intensity images.
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scaffold 3 PDEGMA/S-peptide, with a decrease in CNO− inten-
sity being observed for 4 and 10 PDEGMA/S-peptide (Fig. 2A).
Nor-GGG-YIGSR peptide positive ion fragment signals were
identified and were corroborated to literature30,31 (see frag-
ment structures of identified signals in Fig. S23†). Peptide
fragments were detected for all scaffolds, including the PLA +
PDEGMA (100 : 0) scaffolds (Fig. 2B). This suggested that non-
specific electrostatic binding of the peptide occurred with the
surface of the scaffolds. The distribution images of the signal,
an even distribution of peptide fragment peaks was observed
on the PLA + PDEGMA (100 : 0) scaffold with no thiols present,
without a defined fibre morphology (Fig. 2C). However, in case
of the peptide-derivatised scaffolds, more defined fibre mor-
phologies were found (see Fig. 2C). This observation indicates
the occurrence of specific reaction of the fibre surfaces when
free thiols are available, as well as some, albeit low-level, non-
specific peptide interaction at the surface of the fibres with no
thiols present.
Cell expansion and phenotype support
hCSCs were cultured on the fabricated scaffolds for up to 9
days without loss of scaffold integrity (see protocol ESI section
1†). The media composition of DMEM/F12 with 20% serum re-
placement, fibroblast growth factor and leukaemia inhibitory
factor (SCM) has previously reported to support the keratocyte
phenotype of hCSCs23 and was therefore used in this study.
Enhanced proliferation was observed on the scaffolds with an
increased content of the laminin mimetic peptide sequence
Nor-GGG-YIGSR compared to the PLA + PDEGMA scaffolds
(Fig. 3A). Interestingly, significantly higher proliferation was
also found on PLA with PDEGMA/SH in the fibres (Fig. 3A).
This may be due to presence of free thiols, which promote
protein interaction and therefore cell adherence. Morphology
staining (actin and vimentin for the cytoskeleton) studies
showed clusters of cells on PLA, and PLA with 10 wt%
PDEGMA (100 : 0, Fig. 4 and S25–S28†), elongated cell mor-
phologies on PLA with PDEGMA/SH (90 : 10, Fig. S28†), and an
increase in a spindle-like morphology of the cells on the
peptide derivatised PLA scaffolds with increased PDEGMA/
S-Nor-GGG-YIGSR present (Fig. 4 and S26†). The round mor-
phology of the cells on the PLA, and PLA with 10 wt%
PDEGMA (100 : 0) scaffolds indicated a limited interaction
between the cells and the fibrous scaffold. This in turn
suggested that protein deposition of the media was not
enhanced when the adhesion peptides were merely adsorbed
(as detected by ToF-SIMS analysis) rather than being covalently
bound to the fibre surface. The elongated morphologies of
cells attached to the thiol-functionalised scaffolds was due
most probably to direct cell surface-thiol reactions, for
example via surface exposed cysteines. This assertion is sup-
ported by prior data showing that thiolated surfaces can result
in improved ECM protein adsorption and subsequently
enhanced cell attachment and proliferation.32–34 However, sig-
nificantly more cells exhibiting a spindle-like morphology were
observed when the laminin mimetic sequence YIGSR was
present (see Fig. 4). Uzunalli et al.22 reported a similar mor-
phology of hCSCs when cultured on YIGSR-containing nanofi-
bres compared to fibronectin-mimetic RGD-peptide nanofi-
bres, as well as increased proliferation, supporting the find-
ings reported here.
Immuno-staining of the hCSCs showed the quiescent kera-
tocyte phenotypic markers CD34 and ALDH, and mesenchymal
stem cell (MSC) expression of CD105 on all the different
scaffolds (see Fig. 4 and Fig. S26 and 29†). In addition, the
expression of myofibroblast marker α-SMA was found when
cells were cultured on the PLA and PLA with 10 wt% PDEGMA
(100 : 0) scaffolds, and a very low expression of α-SMA was also
observed when cells were cultured on the PLA fibres with
10 wt% PDEGMA/SH (90 : 10, Fig. S26 and 29†). This indicates
that although the scaffolds with free thiols available do
support cell adherence and proliferation as observed in
Fig. 3A, α-SMA was still expressed indicating the expression of
Fig. 3 (A) Cell proliferation in cells per cm2 of the scaffold different scaffolds types compared to control TCPS over 9 days of culture. (B) Cell pro-
liferation in cells per cm2 of the peptide derivatised scaffolds with different concentration of peptide attached over 9 days of culture (n = 3 scaffolds,
two-way ANOVA, * = <0.05, ** = <0.01, *** = <0.001 and **** = <0.0001, error bars = SD).
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a myofibroblast phenotype. On the other hand, no α-SMA
expression was detected when cells were cultured on any of the
PLA fibres functionalised with 10 wt% PDEGMA/S-Nor-
GGG-YIGSR (90 : 10). These data confirmed that the peptide
supported the quiescent keratocyte phenotype and suppressed
de-differentiation of the keratocytes to their activated myofi-
broblast phenotype.
ECM expression was investigated to confirm the hypotheses
that the free thiol group-containing scaffold supported ECM
expression and adsorption and hence cell adhesion and pro-
liferation as observed in Fig. S28.† Collagen I expression was
observed throughout all the scaffold types (Fig. 4 and S27†),
however, this protein increased in abundance and was more
evenly distributed on the peptide containing scaffolds (Fig. 4
and S27†). While, collagen I expression was observed near to
the clusters of cells on the PLA + PDGEMA (100 : 0) scaffold
with absorbed peptide only (Fig. 4 and S27†). These results
confirmed that PDEGMA/S-Nor-GGG-YIGSR peptide functiona-
lisation on the scaffold led to an increased expression of col-
lagen I.
Stromal keratocytes express the keratan sulphate proteogly-
can, lumican, a corneal transparency factor in a normal unda-
maged cornea.32,33 Lumican interacts with collagen fibrils to
maintain spacing and transparency in a healthy cornea.34
Production is significantly reduced during wound healing and
phenotypic change to a fibroblast morphology, and thus the
presence of lumican can be considered a marker of the quies-
cent phenotype of hCSCs. As apparent from Fig. 4, lumican
expression was found on the scaffolds with peptide present;
including the PLA + PDEGMA (100 : 0) scaffolds with non-
specific bound peptide. No lumican was present on the
scaffold with free thiols, without peptide present (see
Fig. S27†). This indicates that the presence of peptide at the
surface of the fibres supported ECM expression, while free
thiols at the surface do not. However, myofibroblast differen-
tiation and clusters of cells were still observed on the PLA +
PDEGMA (100 : 0) scaffolds, suggesting that the non-specifi-
cally bound peptide did not support strong cell interactions
with the scaffold surface. It was observed that cells spread out
across the surfaces only when the peptide was covalently
bound to the fibres. Increased lumican expression was
detected for the peptide bound scaffolds with 3, 4 and
10 mol% PDEGMA/S-peptide attached, providing support for
assertion (Fig. 4). As the derivatised scaffolds with the Nor-
GGG-YIGSR peptide were observed to promote the desired
quiescent phenotype, spindle-like morphology and ECM
expression, the cellular responses on the surfaces with
different percentages of peptides attached were investigated.
After 9 days cell culture, significantly higher proliferation was
observed for 3 and 10% peptide-derivatised scaffolds (97 : 3
and 90 : 10, Fig. 3B). The expression of the quiescent kerato-
cyte phenotype CD34 and ALDH markers were detected for all
different concentrations of peptide (Fig. 4). A significantly
increased expression of ALDH was observed for the 3 mol%
peptide scaffold. As ALDH expression plays an important role
in the maintenance of corneal transparency, this indicated a
desirable response of the cells in term of their culture on the
derivatised fibres. In addition, CD105 MSC marker expression
was found on all scaffolds, suggestive of a partial loss of the
differentiated quiescent phenotype to a more stem cell-like
phenotype.24 Myofibroblastic α-SMA expression was observed
for those cells cultured on scaffolds containing 2 mol%
peptide (98 : 2, PDEGMA/S-pep) and on the 0% control
(100 : 0), indicating a threshold of peptide content needed to
avoid myofibroblast activation. Peptide concentrations of
2 mol% were too low to support the quiescent phenotype and
resulted in a myo-fibroblastic change, while cells cultured on
scaffolds containing 3, 4 and 10 mol% peptide generated no
α-SMA expression. The previously rounded and cluster cell
morphology was observed on the scaffolds containing 0 and
2 mol% peptide concentrations, while a more fusiform mor-
phology was observed when cultured on scaffolds with
peptide-concentrations 3, 4 or 10 mol% (Fig. 4). Moreover,
lumican ECM expression was detected when cells were cul-
tured on scaffolds with higher percentages of peptide on the
surface (3, 4, and 10 mol%). It can therefore be concluded that
scaffold fibres with more than 2 mol% of Nor-GGG-YIGSR co-
valently bound to their surfaces significantly improved hCSCs
attachment, proliferation, ECM expression and supported a
quiescent cell phenotype.
Enzymatic-free passaging
The PLA with thermo-responsive PDEGMA/S-Nor-GGG-YIGSR
polymer scaffolds were not only designed to improve cell
attachment and phenotype support, but also to prevent cell
damage, which can occur through enzymatic passaging.
Many studies to date have investigated the potential of the
thermo-responsive polymer, PNIPAM, for corneal cell type
detachment.8,35–37 We have recently shown that blend
electrospinning of thermo-responsive polymer poly
(PEGMA188) with a bulk polymer of choice (amenable to
electrospinning) will render the fibres thermo-responsive.
Mammalian cell adhesion, viability, proliferation and pheno-
type on this fibrous culture system over numerous thermal
enzyme-free passages was achieved.38 However, no other
studies are reported to date utilising such thermo-responsive
scaffolds for human primary cell culture. A preliminary
experiment illustrating the ability to culture and detach cells
from the PLA + PDEGMA and PLA + PDEGMA/S-Nor-
GGG-YIGSR-containing scaffolds, and the subsequent quan-
titative assessment of the cell phenotype by flow cytometry
analysis (FACS), was performed. hCSCs grown on peptide-
derivatised fibrous scaffolds containing 10 wt% of different
molar ratios of PDEGMA/S-pep were passaged after 9 days of
cell culture at 37 °C by placing the scaffolds in the fridge for
30 min at 4 °C (section 1 ESI†). Cell detachment was
observed from all scaffolds (Fig. 5A). This demonstrates the
thermo-responsive passaging capability of the scaffold con-
taining peptide on the surface. However, fluctuating percen-
tages of cells detached were observed from some of the 2 and
10 mol% PDEGS-Nor-GGG-YIGSR (98 : 2, 90 : 10) containing
scaffolds (Fig. 5A). This may have been due to heterogeneous
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cell attachment to the lowest percentage peptide derivatives
(PDEGMA/S-Nor-GGG-YIGSR (98 : 2)) and very strong
adhesion to the more extensively peptide-functionalised
fibres (PDEGMA/S-Nor-GGG-YIGSR (90 : 10)). Nonetheless,
more consistent cell detachment was observed from the
scaffolds containing 3 and 4 mol% PDEGS-Nor-GGG-YIGSR
(97 : 3 and 96 : 4). The presence of extracellular matrix after
detachment was not investigated in this work and will be
included in future work.
Flow cytometry analysis of cell surface markers of cells
detached from the scaffolds was carried out to validate
immuno-staining findings. Cells cultured on 3 mol% peptide
scaffolds were observed to have an increased sub-population
of 16% of cells that only expressed the CD34+/CD105− kerato-
cyte marker (Fig. 5B and Tables S8–9†) compared to those cul-
tured on all other scaffolds. However, CD34−/CD105+ and
CD34+/CD105+ sub-populations combined constituted half of
the total cell population (53%, Table S8†) whereas CD34+/
CD105+ and CD34+/CD105− cells comprised 45% (Table S8†)
of the total cell population. Therefore, a significant percen-
tage of the population exhibited MSC characteristics besides
those of the desired keratocyte CD34 marker. A similar sub-
population percentage of CD34−/CD105+ and CD34+/CD105+
cells (51%, Table S8†) was detected when cultured on the
scaffolds with 4 mol% peptide on the surface, nevertheless
there was an increase in the proportion of cells which
expressed the CD34 marker (38% of total cell population,
Table S8†). Significantly less CD34+/CD105+ expression was
observed for all scaffolds compared to the 2D TCPS control
when comparing the Y-mean (Table S9†). This observation
Fig. 5 (A) Percentage of cells detached after thermo-responsive passaging of the different concentrations of peptide on the surface (n = 3
scaffolds, two-way ANOVA, error bars = SD). (B) Flow cytometry percentage of cell population expressing the desired keratocyte marker CD34 and/
or mesenchymal stem cell marker CD105 after thermo-response detachment from the different scaffolds (n = 3 cells detached from 3 scaffolds per
scaffold type, control cell passage with trypsin from TCPS). (C) Flow cytometry percentage of cell population expressing the desired keratocyte
marker ALDH and/or the undesired myo-fibroblastic marker α-SMA after thermo-response detachment from the different scaffolds (n = 3 cells
detached from 3 scaffolds per scaffold type, control cell passage with trypsin from TCPS). (D) Combined percentage of cell population that expresses
α-SMA on the different scaffolds (n = 3 cells detached from 3 scaffolds per scaffold type, control cell passage with trypsin from TCPS, * = <0.05).
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shows that the 3D culture environment significantly reduced
the expression of the MSC marker CD105, while no significant
difference was seen for the different molar percentage content
of peptides (Tables S8 and S10–11†). In addition, an increased
expression of ALDH+/α-SMA− was demonstrated when cells
were cultured on 3 and 4 mol% peptide scaffolds (Fig. 5C). In
terms of the total cell population, 24, 28, 19 and 32%
(ALDH−/α-SMA+ and ALDH+/α-SMA+ combined, Table S8†) for
2, 3, 4 and 10 mol% peptide-functionalised fibres, respect-
ively, were shown to express the α-SMA activated myofibroblas-
tic marker. This was significantly less than the 93% and 43%
observed for the 2D control and PLA + PDEGMA scaffold
respectively. Hence, the 3D structure of the scaffolds contain-
ing covalently bound peptide on the surface reduced the
differentiation to the undesired activated myo-fibroblastic
phenotype compared to the 2D control. Although no signifi-
cant difference could be observed between the scaffolds for
CD34/CD105 expression, a significant decrease of ALDH−/
α-SMA+ was seen for the scaffolds with 3 and 4 mol% peptide
compared to 2D and the adsorbed peptide scaffold when com-
paring the X-mean (Tables S8–11†). This gives an indication
that the covalently attached peptide reduced the change to the
activated myofibroblast phenotype and supported increased
ALDH expression.
In general terms, these data were in accord with the
improved results in 3D fibrous scaffolds for cell culture and
tissue engineering compared to 2D cultures reported in recent
years.39–43 The fibrous structure in these materials was
designed to mimic ECM properties, resulting in an increase in
desired cell response. However, as the synthetic polymers used
in our culture assays were non-native to the cells, we antici-
pated that peptide or protein incorporation or functionalisa-
tion would be required to overcome some key practical chal-
lenges. These included poor cell attachment and induction of
inflammation or undesired cell differentiation due to the sub-
optimal mechanical or chemical properties (such as stiffness
and hydrophobicity) of conventional polymer fibres.39–43 For
example, Rodina et al.42 investigated migration and prolifer-
ation of mesenchymal stromal stem cells (MSSCs) on collagen
protein modified PLA fibrous scaffolds. They observed more
uniform distribution and cell penetration into these modified
scaffolds. In addition to proteins, more specific peptide
sequences can be used as ligands for enhanced cell attach-
ment. The Arg-Gly-Asp (RGD) collagen/fibronectin peptide
sequence is the most commonly used peptide incorporated in
biomaterials to increase their cell adhesion properties.44
Besides, incorporation of known cell attachment peptide
sequences (such as RGD), more cell specific peptide sequences
can be incorporated to improve selective cell function or differ-
entiation on the materials.45 Examples include the laminin-
derived peptides IKVAV46 and YIGSR47 for cell attachment and
anti-cancerous response, specific bone morphogenetic protein-
2-related peptide P24 and rhBMP2,
48,49 MMP degradable
peptide sequences50 and enzyme responsive peptides (such as
Fmoc-propargyl-GAARGD, which can be cleaved to ARGD by
the enzyme elastase expressed by porcine pancreas).51
In this study, we set out a new approach for 3D mammalian
cell culture by functionalising thermo-responsive fibrous
scaffolds with a cell responsive peptide sequence. The method-
ology employed here to functionalise the scaffolds is amenable
to the attachment of other peptide sequences as desired. In
our case the laminin-1 peptide component, YIGSR, known to
promote hCSCs interaction and to support the quiescent kera-
tocyte culture on the scaffolds was chosen as an exemplar.22
Previous studies have demonstrated that laminin improves
growth, organisation and differentiation of many cell
types.22,52–55 Nonetheless, the use of laminin has many disad-
vantages such as degradation in culture to inactive fragments,
tumorigenesis and induction of immune-responses, which
make the full sequence unsuitable for clinical application.56
This risk can be minimised by selecting small peptide
sequences within the laminin structure, which have the ability
to improve adhesion and cell migration. One of these
sequences is YIGSR, which has been observed to improve cell
adhesion and migration.57–61 For example, Uzunalli et al.22
investigated the response of hCSCs on bioactive self-assembled
peptide nanofibres. Two peptide sequences were investigated;
(1) YIGSR (laminin derived) and (2) RGD (fibronectin derived).
In both these cases, hCSCs were observed to maintain their
characteristic morphology, and their proliferation was
enhanced when YIGSR was present. Significantly, less cell pro-
liferation and adhesion was observed for the RGD fibres. This
study suggested that the YIGSR sequence has a direct impact
on hCSCs attachment, proliferation and migration on 3D struc-
tures. These observations are in line with the increase in pro-
liferation of the hCSCs observed on our scaffolds with increas-
ing molar ratio of GGG-YIGSR covalently bound on the
surface. Many studies have reported improved attachment and
proliferation of human cornea epithelial cells.61–65 However,
only one paper has described the response of hCSCs on YIGSR
incorporated scaffolds,22 and no phenotypic support study has
been performed to our knowledge. The immuno-staining and
flow cytometry data reported here suggests that not only does
YIGSR enhance cell attachment and proliferation on the
fibrous scaffold, but the peptide also supports a higher percen-
tage of the cell population which expresses a quiescent pheno-
type. Down-regulation of the undesired myofibroblastic
marker α-SMA was detected, while up-regulation of keratocyte
markers CD34 and ALDH was observed. Phenotypic character-
istics were observed to remain constant when cultured and
passaged, by the thermo-responsive enzymatic free passaging
capabilities of the scaffolds. This gives an indication that such
scaffolds can be designed to support the desired cell pheno-
type during in vitro culture and enzyme-free passaging and
therefore this system is suitable for therapeutically relevant
cell types.
Conclusions
The peptide functionalised, thermo-responsive electrospun
scaffolds described here were designed for human cornea
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stromal cells (hCSCs) proliferation, phenotype support and
enzymatic digestion-free passaging. The initially proposed
scaffolds (PLA with 10 wt% PDEGMA) did not facilitate hCSCs
adhesion and proliferation. Therefore, a peptide-functionalised
scaffold was produced to improve the attachment of hCSCs on
the scaffold and support the desired quiescent phenotype.
PDEGMA/SH polymers were accordingly synthesised, their
thermo-responsive properties and thiol content confirmed, and
the materials were successfully blend-electrospun with PLA into
fibrous scaffolds. The presence and homogenous distribution
of free thiol on the scaffold surfaces, and the subsequent conju-
gation of Nor-GGG-YIGSR was confirmed by ToF-SIMS analysis.
Non-specific attachment of the peptide was observed on
thermo-responsive fibres without free thiol functionality but
microscopy studies showed aggregated cells on these scaffolds,
while elongated and spread cell morphologies were observed on
thiol-containing and covalently-bound peptide derivatised
scaffolds. These data indicated that enhanced hCSCs inter-
action was dependent on covalent peptide-functionalisation of
the thermo-responsive fibres. The undesired, activated myofi-
broblastic phenotype was observed to decrease with increased
molar percentage of Nor-GGG-YIGSR conjugated polymers at
the scaffold’s surface. The highest levels of peptide-functionali-
sation resulted in a decrease in keratocyte specific markers
ALDH and CD34, whereas concentrations of 3 and 4 mol% Nor-
GGG-YIGSR resulted in the highest expression of keratocyte
markers, while suppressing the active myofibroblastic pheno-
type. Between 80–100% of cultured cells were observed to
detach from the scaffolds at temperatures below the phase tran-
sition temperature of the thermo-responsive polymers at the
surfaces of the fibres. Despite some variation in detachment of
the cells from the scaffolds, cells were able to retain their cell
phenotype after thermal cycles of attachment and detachment
passaging. Hence, it can be concluded that the designed
peptide conjugated thermo-responsive fibrous scaffolds are
suitable for the attachment, proliferation, quiescent keratocyte
phenotype support and temperature-mediated-passaging of
hCSCs. In our studies, we used a peptide sequence to aid in
hCSCs cell culture and expansion, but the attached peptide
sequence could easily be changed to select for a different cell
type, making the fabricated scaffolds a versatile matrix for cell
expansion and phenotype support of any cell type including
those destined for the clinic.
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